Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses
Ontology highlight
ABSTRACT: Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses
PROVIDER: PRJNA540471 | ENA |
REPOSITORIES: ENA
ACCESS DATA